drugset / Trial / NCT03305055
RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain
Phase 4
Terminated
4 enrolled
Johns Hopkins University
Congressionally Directed Medical Research Programs · collabUnited States Department of Defense · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The Ketamine for Acute Pain in Burns study is a randomized, double-blind, parallel group trial (RCT) with active control (usual care) contrasting the efficacy and safety of "Ketamine Plus Opiate-based usual care" (O+K) with the safety and efficacy of the "Current Standard of Care". THe current standard of care is an opiate medication alone, Fentanyl (Usual Care-Opiate (UC-O), dose/timing as per Burn Center protocol).
Timeline
- Start
- 2017-12-16
- Primary completion
- 2018-03-28
- Completion
- 2018-04-21
Outcome
Outcome not reported
Stopped (Enrollment): “Funding withdrawn - slow enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 2.5 ug/kg | Other |
| Background | Fentanyl | Other / unclassified | 1 ug/kg | Other |